Ann Livingstone
@_AnnLiv
Followers
501
Following
4K
Media
99
Statuses
405
Health Economist recently minted PhD interested in trade-offs, DCEs and preferences. Mum, martial artist, avid cyclist & lover of colour @DHE_Deakin @IHT_Deakin
Sydney, New South Wales
Joined November 2018
New Cancer Information & Support Services Systematic Review protocol paper out now! Dive into the latest research at https://t.co/S3fd7CoEIP…. Your comprehensive guide to understanding #Cancer info & support #Healthcare #Research
@CancerVic @IHT_Deakin
@nikki_mccaffrey
2
0
3
New study led by DHE A/Prof Nikki McCaffrey @nikki_mccaffrey identifies 8 quality-of-life domains crucial for patients, revealing gaps in current preference-based measures. A fresh approach is needed, recognizing and valuing what matters most to patients.
0
2
5
Congrats @ProfGLongMIA and @ProfRScolyerMIA such inspirational and innovative work
On @abcsydney @ProfGLongMIA explains advances made in melanoma treatment & how they're being applied to @ProfRScolyerMIA's brain cancer. Prof Long & Prof Scolyer have been jointly nominated for NSW Australian of the Year. @ausoftheyear #AusoftheYear
https://t.co/ifydAZ1oFK
0
0
1
Calling all Health Economists 📢Applications close in one week! 🌟Job Opportunity: DELIVER Research Fellow🌟 @IHT_Deakin
https://t.co/KbYqTA0l1E
0
1
1
✨CALL FOR PARTICIPANTS ✨ If you are 18-25, living in #Autralia 🇦🇺 and having #anxiety or #depression in the past 12 months, please take our 15-minute survey and get a chance to WIN $100. ✅Survey link: https://t.co/D9e93nnE8X Please share! #MentalHealth #MentalHealthMatters
0
4
5
Congratulations @ha_le1701 on receiving a @DeakinHealth Research Capacity Building Grant Scheme (HAtCH) to be able to conduct your important research into the cost and wait-time of private ADHD health services.
I’m so excited to receive the funding to conduct this important research: the cost and wait time of private ADHD services @AustAADPA
0
2
13
Promotion announcements are out - and a big congratulations to two of @DHE_Deakin's new Assoc. Prof's @JaithriA and Lan Gao 🎉🎉🎉🙌 @IHT_Deakin
3
2
20
0
2
9
A BIG congrats to @SeanRandall6 and the entire LinXmart team for being runners-up for the Data Innovation Award @ResAustralia last night! @IHT_Deakin 🎉🎉🎉🎖️🎖️🎖️
0
2
9
The LinXmart team are runners up! Well done on highly commended. We are proud of the boys! @DHE_Deakin @IHT_Deakin @ResAustralia
0
3
11
I’m so excited to receive the funding to conduct this important research: the cost and wait time of private ADHD services @AustAADPA
Congratulations to Dr. Ha Le @ha_le1701 on receiving @DeakinHealth Research Capacity Building Grant Scheme (HAtCH) for her project: ⭐️Assessing the cost and wait-time of ADHD health services⭐️@IHT_Deakin
9
3
36
Congratulations to Dr. Ha Le @ha_le1701 on receiving @DeakinHealth Research Capacity Building Grant Scheme (HAtCH) for her project: ⭐️Assessing the cost and wait-time of ADHD health services⭐️@IHT_Deakin
1
2
10
1
0
0
Join @DieuNguye1 at #AHES2023 at 1040am today to learn about her fascinating research 'The temporal change in life expectancy of Chronic Lymphocytic Leukaemia patients in Australia' Don’t miss out! #CLL #HealthEconomics @IHT_Deakin
0
1
1
🤔 Can't choose which parallel session #AHES2023! "Smoking, quitting, and vaping" @nikki_mccaffrey & @anitalal8 brings health econ insights, while "Modelling alcohol harms in Australia" @jaithriA & Mary Rose Angeles delves into policy interventions. #ConferenceDilemma @IHT_Deakin
0
1
6
🌟 Let's give @LeeThePeter a round of applause for an amazing and informative presentation "An Intersectional Approach to Quantifying the Impact of Geographic Remoteness and Health Disparities on Quality-Adjusted Life Expectancy: Application to Australia" @IHT_Deakin #AHES2023
0
1
6
Excited for my 1st AHES in Adelaide Denzel Fiebig kicking off about “machine learning in health economics”, we all know regression #AHES2023 @AusHealthEcon
1
1
7
Thanks @thelimbiconc for sharing my preference research about #adjimmuno #melanoma @RachaelMorton12 @MartinStockler @amenzies9 @ProfGLongMIA Kirsten Howard @TrialsCentre @DHE_Deakin @IHT_Deakin
Most patients with resected stage III melanoma would opt for adjuvant checkpoint inhibitor immunotherapy if given the choice, results from an Australian survey suggest. https://t.co/7N2rCGBswU
0
0
4
Latest work final PhD manuscript published 🎉 @RachaelMorton12 @MartinStockler @amenzies9 @ProfGLongMIA Kirsten Howard @IHT_Deakin @DHE_Deakin @TrialsCentre
Recently published in @PatientJournal: Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment By @_AnnLiv & colleagues #Melanoma #PatientPreferences 👉 https://t.co/6k34yS0yh1
1
3
18